SCHEMBL16686972

SCHEMBL16686972

CCOC(=O)Oc1cn2ccc(N)cc2n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.48
POLB P06746 2/20 0.48
TLR9 Q9NR96 2/20 0.42
TLR7 Q9NYK1 2/20 0.42
MAPT P10636 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
TDP1 Q9NUW8 2/20 0.41
PKM P14618 1/20 0.41
SUV39H2 Q9H5I1 4/20 0.40
ALDH1A1 P00352 3/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
ADORA3 P0DMS8 2/20 0.35
CA2 P00918 1/20 0.35
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
LMNA P02545 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
MAOA P21397 1/20 0.34
TP53 P04637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16685207 0.82 KDM4E (0.41) KDM4EPOLBMAPTSMN1; SMN2TDP1
SCHEMBL16687074 0.81 KDM4E (0.44) KDM4EPOLBMAPTSMN1; SMN2TDP1
SCHEMBL4031415 0.80 ALDH1A1 (0.53) KDM4EPOLBMAPTSMN1; SMN2PKM
SCHEMBL16691126 0.79 KDM4E (0.76) KDM4EPOLBTLR9TLR7MAPT
SCHEMBL15418923 0.71 KDM4E (0.39) KDM4EPOLBMAPTSMN1; SMN2ALDH1A1
SCHEMBL15418875 0.71 PIK3CA (0.42) KDM4EPOLBMAPTSMN1; SMN2ALDH1A1
SCHEMBL16686872 0.70 RAB9A (0.50) KDM4EPOLBMAPTSMN1; SMN2ALDH1A1
SCHEMBL15419068 0.70 RAB9A (0.42) KDM4EPOLBMAPTSMN1; SMN2ALDH1A1
SCHEMBL18026511 0.68 TLR9 (0.49) KDM4EPOLBTLR9TLR7MAPT
SCHEMBL2440400 0.68 NR4A2 (0.53) KDM4EPOLBSMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3063150-B1 SUBSTITUTED OXOPYRIDINE DERIVATIVES Bayer Pharma AG (DE) 2017-11-22 EP disclosed
EP-3063150-A1 SUBSTITUTED OXOPYRIDINE DERIVATIVES Bayer Pharma Aktiengesellschaft (DE) 2016-09-07 EP disclosed
WO-2015063093-A1 SUBSTITUTED OXOPYRIDINE DERIVATIVES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2015-05-07 WO disclosed